Inspiral 10 SR is a sustained-release generic formulation of methylphenidate, designed to manage symptoms of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. This 10mg dose delivers controlled therapeutic effects over several hours, reducing the need for multiple daily doses. It enhances focus, regulates impulsive behavior, and supports improved academic and social performance.

- Sleep & Mental Health > ADHD (Attention Deficit Hyperactivity Disorder) Inspiral 10 SR is widely prescribed for ADHD, offering effective symptom control by increasing focus, reducing hyperactivity, and improving behavioral responses. It helps both pediatric and adult patients maintain attention and manage daily tasks with greater consistency. > Improve memory, concentration and brain function Methylphenidate is sometimes used off-label for cognitive enhancement. Though not medically endorsed for this use, it is sought for its ability to increase mental stamina, boost concentration during study or work, and improve working memory. > Autism In certain cases of autism spectrum disorder, Inspiral 10 SR is used adjunctively to reduce hyperactivity, improve attention, and manage impulsivity. Its role is particularly important when behavior therapy alone is insufficient.

Methylphenidate acts by inhibiting the reuptake of dopamine and norepinephrine, enhancing their availability in the synaptic cleft. This stimulation of the central nervous system leads to improved attention, reduced restlessness, and enhanced cognitive control—critical for those with ADHD and related conditions.

Adults – ADHD & Narcolepsy Immediate-Release (IR): - Typical: 20–30 mg/day in 2–3 divided doses before meals - Max: 60 mg/day - Titrate gradually based on patient response Extended-Release (ER): - Dose conversion based on previous IR exposure - Do not interchange products mg-for-mg - Titrate weekly - Max: 72–100 mg/day depending on formulation Pediatrics (6+ years) – ADHD & Narcolepsy Immediate-Release (IR): - Start: 5 mg twice daily (before breakfast & lunch) - Increase: 5–10 mg/week as needed - Max: 60 mg/day Extended-Release (ER): - Once-daily dosing preferred - Titration based on age/weight and IR history - Max: 6–12 years: 54 mg/day | 13+ years: 72 mg/day or 2 mg/kg/day Other Forms: - Patch, suspension, and ODT options available for patients with swallowing difficulties General Clinical Considerations - Weekly titration recommended - Treatment should be individualized - Discontinue if ineffective after 1 month - Monitor for: insomnia, appetite suppression, mood swings - Consistent administration schedule with/without food - Different release mechanisms require careful product selection

Store below 25°C in a dry, well-sealed container. Keep away from direct sunlight, moisture, and heat. Ensure the product is out of reach of children. Do not freeze. Follow expiry date instructions for safety.

Common side effects include decreased appetite, difficulty sleeping, nervousness, dry mouth, and stomach discomfort. Some patients may experience irritability or mild increases in blood pressure and heart rate. Rare effects include tics, mood changes, or hallucinations. Long-term use in children may affect growth; monitoring is essential.